High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$271K
$271,084
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Wilson Martin
• Officer • General Counsel
Sell to Cover
2026-02-18
$4,593
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • General Counsel
Sell to Cover
|
2026-02-18 | $4,593 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Sell to Cover
2026-02-18
$3,862
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Sell to Cover
|
2026-02-18 | $3,862 | S | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-02-18 | $19,995 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Wilson Martin
• Officer • General Counsel
Sell to Cover
2026-02-13
$40,582
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • General Counsel
Sell to Cover
|
2026-02-13 | $40,582 | S | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-02-13 | $40,668 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Sell to Cover
2026-02-13
$12,341
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Sell to Cover
|
2026-02-13 | $12,341 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Discretionary Sell
2025-11-18
$3,240
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Discretionary Sell
|
2025-11-18 | $3,240 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Schwartz Jonathan David
• Officer • See Remarks
Discretionary Sell
2025-11-18
$7,592
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Discretionary Sell
|
2025-11-18 | $7,592 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Wilson Martin
• Officer • General Counsel
Discretionary Sell
2025-11-18
$4,910
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • General Counsel
Discretionary Sell
|
2025-11-18 | $4,910 | S | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-11-18 | $18,721 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Discretionary SellΔOwn -20.7%
2025-10-14
$78,570
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Discretionary SellΔOwn -20.7%
|
2025-10-14 | $78,570 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Discretionary Sell
2025-10-14
$21,863
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Discretionary Sell
|
2025-10-14 | $21,863 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Discretionary Sell
2025-10-14
$11,930
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Discretionary Sell
|
2025-10-14 | $11,930 | S | Form 4 |
|
RCKT
S
ROCKET PHARMACEUTICALS, INC.
Militello John
• Officer • See Remarks
Discretionary Sell
2025-10-14
$2,218
|
||||||
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Officer • See Remarks
Discretionary Sell
|
2025-10-14 | $2,218 | S | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Director
Other
|
2025-09-19 | $1,050,861Large | X | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Director
Other
|
2025-09-19 | $782,756 | X | Form 4 |
| RCKT |
ROCKET PHARMACEUTICALS, INC.
|
Director
Other
|
2025-09-19 | $40,032,400MEGA | X | Form 4 |